Literature DB >> 17268527

Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia.

A Yoshimi, M Mohamed, M Bierings, C Urban, E Korthof, M Zecca, K-W Sykora, U Duffner, M Trebo, S Matthes-Martin, P Sedlacek, T Klingebiel, P Lang, M Führer, A Claviez, W Wössmann, A Pession, J Arvidson, A S O'Marcaigh, M M van den Heuvel-Eibrink, J Starý, H Hasle, P Nöllke, F Locatelli, C M Niemeyer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17268527     DOI： 10.1038/sj.leu.2404537

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  13 in total

1.  Subclonal mutations in SETBP1 confer a poor prognosis in juvenile myelomonocytic leukemia.

Authors:  Elliot Stieglitz; Camille B Troup; Laura C Gelston; John Haliburton; Eric D Chow; Kristie B Yu; Jon Akutagawa; Amaro N Taylor-Weiner; Y Lucy Liu; Yong-Dong Wang; Kyle Beckman; Peter D Emanuel; Benjamin S Braun; Adam Abate; Robert B Gerbing; Todd A Alonzo; Mignon L Loh
Journal:  Blood       Date:  2014-11-13       Impact factor: 22.113

2.  Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium.

Authors:  Rebecca J Chan; Todd Cooper; Christian P Kratz; Brian Weiss; Mignon L Loh
Journal:  Leuk Res       Date:  2008-10-26       Impact factor: 3.156

Review 3.  RAS diseases in children.

Authors:  Charlotte M Niemeyer
Journal:  Haematologica       Date:  2014-11       Impact factor: 9.941

4.  Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.

Authors:  Elliot Stieglitz; Ashley F Ward; Robert B Gerbing; Todd A Alonzo; Robert J Arceci; Y Lucy Liu; Peter D Emanuel; Brigitte C Widemann; Jennifer W Cheng; Nalini Jayaprakash; Frank M Balis; Robert P Castleberry; Nancy J Bunin; Mignon L Loh; Todd M Cooper
Journal:  Pediatr Blood Cancer       Date:  2014-12-08       Impact factor: 3.167

Review 5.  Hematopoietic stem cell transplantation for leukemia.

Authors:  Alan S Wayne; Kristin Baird; R Maarten Egeler
Journal:  Pediatr Clin North Am       Date:  2010-02       Impact factor: 3.278

6.  Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan.

Authors:  Miharu Yabe; Yoshitoshi Ohtsuka; Kenichiro Watanabe; Jiro Inagaki; Nao Yoshida; Kazuo Sakashita; Harumi Kakuda; Hiromasa Yabe; Hidemitsu Kurosawa; Kazuko Kudo; Atsushi Manabe
Journal:  Int J Hematol       Date:  2014-12-11       Impact factor: 2.490

7.  Activating PTPN11 mutants promote hematopoietic progenitor cell-cycle progression and survival.

Authors:  Zhenyun Yang; Yiping Li; Fuqin Yin; Rebecca J Chan
Journal:  Exp Hematol       Date:  2008-07-21       Impact factor: 3.084

8.  An International MDS/MPN Working Group's perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms.

Authors:  Tariq I Mughal; Nicholas C P Cross; Eric Padron; Ramon V Tiu; Michael Savona; Luca Malcovati; Raoul Tibes; Rami S Komrokji; Jean-Jacques Kiladjian; Guillermo Garcia-Manero; Attilio Orazi; Ruben Mesa; Jaroslaw P Maciejewski; Pierre Fenaux; Raphael Itzykson; Ghulam Mufti; Eric Solary; Alan F List
Journal:  Haematologica       Date:  2015-09       Impact factor: 9.941

9.  Increased c-Jun expression and reduced GATA2 expression promote aberrant monocytic differentiation induced by activating PTPN11 mutants.

Authors:  Zhenyun Yang; Takako Kondo; Cara S Voorhorst; Sarah C Nabinger; Leila Ndong; Fuqin Yin; Edward M Chan; Menggang Yu; Oliver Würstlin; Christian P Kratz; Charlotte M Niemeyer; Christian Flotho; Eri Hashino; Rebecca J Chan
Journal:  Mol Cell Biol       Date:  2009-06-15       Impact factor: 4.272

Review 10.  Juvenile myelomonocytic leukemia: epidemiology, etiopathogenesis, diagnosis, and management considerations.

Authors:  Ayami Yoshimi; Seiji Kojima; Naoto Hirano
Journal:  Paediatr Drugs       Date:  2010       Impact factor: 3.022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.